FierceBiotech takes a publishing holiday

It's been a great first quarter here at FierceBiotech. We've welcomed a new sister publication, FierceMedicalDevices, while seeing two newcomers--FiercePharmaManufacturing and FierceBiotechIT--gain ground rapidly in their respective fields. I've even welcomed a few biotech news junkies as Twitter followers. Check it out if you have a few minutes.

In the meantime, tomorrow is a market holiday, and we'll be taking a three day weekend with the market. We'll see you again on Monday. - John Carroll (email | twitter)

Suggested Articles

I-MAB's anti-GM-CSF drug works "upstream" in inflammation pathways, potentially blocking several dangerous cytokines in COVID-19, executives…

Antibe's lead drug beat placebo at reducing osteoarthritis pain, boosting its case as an alternative to NSAIDs, commonly used to treat the condition.

The trial marks the start of a new phase of the response to SARS-CoV-2 in which people will receive drugs designed specifically for the virus.